Chas P. Smith & Associates (CPS)’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Chas P. Smith & Associates (CPS)'s LLY Position: Q1 2026 in Review
Chas P. Smith & Associates (CPS) increased its Eli Lilly (LLY) stake by 3.3% in Q1 2026, buying an estimated $40.6K and bringing the position to 1,254 shares worth $1.15M. The position accounts for 0.06% of the portfolio, ranked #72.
Chas P. Smith & Associates (CPS) first reported a position in LLY in Q2 2021 and has held it in 20 quarters since. The position peaked at $1.39M in Q2 2024. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Chas P. Smith & Associates (CPS) held 1,254 shares of Eli Lilly worth $1.15M as of Q1 2026.
- Chas P. Smith & Associates (CPS) bought 40 Eli Lilly shares in Q1 2026, an estimated $40.6K.
- Eli Lilly made up 0.06% of Chas P. Smith & Associates (CPS)'s portfolio in Q1 2026, its #72 holding.
- Chas P. Smith & Associates (CPS) first reported a position in Eli Lilly in Q2 2021 and has held it in 20 quarters since.
- Chas P. Smith & Associates (CPS)'s Eli Lilly position peaked at $1.39M in Q2 2024.
- 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Chas P. Smith & Associates (CPS)'s 13F filing for Q1 2026, filed 12 May 2026.